ERBB2 and breast carcinoma: To the best of our knowledge, PREDICT is the only publicly available, free, online tool developed to predict individual prognosis in the specific population of patients with HER2-positive early breast cancer based on traditional and easily retrieved clinical-pathological factors including HER2.